Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma
Authors:
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 18 (3) , 196-202
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 58 references indexed in Scilit:
- 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signalingInternational Journal of Oncology, 2013
- BlueBerry Isolate, Pterostilbene, Functions as a Potential Anticancer Stem Cell Agent in Suppressing Irradiation-Mediated Enrichment of Hepatoma Stem CellsEvidence-Based Complementary and Alternative Medicine, 2013
- Herbal Compound “Songyou Yin” Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of StemnessEvidence-Based Complementary and Alternative Medicine, 2012
- Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulationsJournal of Hepatology, 2011
- Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal TransitionPLOS ONE, 2011
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell ExpansionCancer Research, 2010
- Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulationHepatology, 2010
- Dietary intake of pterostilbene, a constituent of blueberries, inhibits the -catenin/p65 downstream signaling pathway and colon carcinogenesis in ratsCarcinogenesis, 2010
- Herbal extract “Songyou Yin” inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potentialJournal of Cancer Research and Clinical Oncology, 2009